Skip to content

DR CHRISTOPHE DELCORDE

Active
Private limited companyfounded 2005active for 21 yearsAvenue de Marlagne 151, 5000 Namur, BelgiumKBO/BCE: BE 0874.368.886

From the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR CHRISTOPHE DELCORDE has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €34,363 and a net result of €500,566. Equity has been stable since 2018 (±1.4% per year). Its solvency ranks better than 10% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 09-06-2005 Normal situation
Legal form
Private limited company
Registered office
Avenue de Marlagne 151, 5000 Namur
Activity
Specialist medical practice NACE 86220
Establishment unit
2.253.768.175 5000 Namur, since 09-06-2005
Financial year end
31 December
Peppol
Reachable since 14-12-2025

Board and ownership

Shareholders

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€754,804
▲ 19.1%
Turnover
≈ €1.2m
estimated
Profit
€500,566
▲ 15.5%
Equity
€34,363
▲ 1.7%
Total assets
€683,926
▲ 22.5%
Staff
1 FTE
=
2025 accounts filed 3 days after the deadline
Filed on 03-08-2026at the National Bank
Score breakdownraises riskEquity €34,363 (5.0% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €683,926Figures for financial year 2025 (filed on 04-08-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 34% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 30-1
equity 5.0% of total assets
Liquidity 27=
short-term debt 87.2% · cash 20.6%
Profitability 100=
return on assets 73.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.46 (0.41 in 2024), below 1. Short-term debt is 87.2% and cash 20.6% of total assets. 95% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 10% of them on solvency, 5% on liquidity, 80% on profitability and 41% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €683,926
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €34,363 (5.0% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 04-08-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 20678 sector peers (2025).
NBB · sector comparison
Position among 20678 sector peers
Solvency
better than 10%
← weakest strongest →
raises risk · 2025 accounts filed 3 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-08-2026, 3 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
3 days late
2024
13 days late
2023
43 days early
2022
32 days early
2021
34 days early
2020
3 days early
2019
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 18 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (4 of the last 5 filed years within 35 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 89% of companies in human healthsector median 63.0% · 20,678 companies 5.0% View
  • Positive: 8 profitable years in a rowprofit 2025: €500,566 8 years View

Documents

Annual accounts at the NBB

All 20 annual accounts

Articles and registers

Key facts about DR CHRISTOPHE DELCORDE

What is the company number of DR CHRISTOPHE DELCORDE?
The company number of DR CHRISTOPHE DELCORDE is 0874.368.886. The VAT number is the same number with BE in front: BE 0874.368.886.
Where is DR CHRISTOPHE DELCORDE based?
The registered office is at Avenue de Marlagne 151, 5000 Namur.Company details
What does DR CHRISTOPHE DELCORDE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR CHRISTOPHE DELCORDE?
The legal form of DR CHRISTOPHE DELCORDE is Private limited company (BV).
When was DR CHRISTOPHE DELCORDE founded?
DR CHRISTOPHE DELCORDE was founded on 09-06-2005.
Is DR CHRISTOPHE DELCORDE still active?
Yes, DR CHRISTOPHE DELCORDE is an active enterprise in the KBO register.
How many employees does DR CHRISTOPHE DELCORDE have?
DR CHRISTOPHE DELCORDE had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR CHRISTOPHE DELCORDE?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €754,804 and 36 comparable companies (NACE 862). It probably lies between €1.0m and €1.5m.
Is DR CHRISTOPHE DELCORDE profitable?
In financial year 2025, DR CHRISTOPHE DELCORDE made a profit of €500,566.
Where can I find the annual accounts of DR CHRISTOPHE DELCORDE?
DR CHRISTOPHE DELCORDE filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR CHRISTOPHE DELCORDE due?
DR CHRISTOPHE DELCORDE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as DR CHRISTOPHE DELCORDE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €610,000 and €808,000, founded between 2001 and 2008.

CompanyTotal assetsGross margin
DR CHRISTOPHE DELCORDE Namur€683,926€754,804
DOCTEUR GILLES MARECHAL Liège€610,311€826,622
VEPP Saint-Nicolas€763,951€831,488
DELHAYE DAMIEN Mouscron€808,445€638,908
DOKTER DE MEULDER FREDERIC Wommelgem€755,337€597,414
DOKTER ROGER VAN RIET Schilde€736,654€612,161
DOKTER CAROLINE CARDYN Knokke-Heist€698,223€558,437
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.